🔎 Trials Near Me

Akèy › Maladi dejeneratif nè › Kalifòni

Etid klinik pou Maladi dejeneratif nè nan Kalifòni

10 etid pou Maladi dejeneratif nè ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Anaheim
  • Clinical Site, Long Beach
  • Clinical Site, Murrieta
  • ak 2 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

A Study of LY3439539 in Participants With Alzheimer's Disease

  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • Inglewood Clinical, Los Angeles
  • ak 1 plis
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Profound Research LLC, Carlsbad
  • Irvine Clinical Research, Irvine
  • UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
  • ak 1 plis
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Parkinson Progression Marker Initiative Online (PPMI Online)

  • UCSF Movement Disorders and Neuromodulation Center (MDNC), San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05065060

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

  • UCLA Ataxia Center, Los Angeles
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 1, 2026 · NCT06016946

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

  • University of California, San Diego, La Jolla
Ap rekriteFaz 1
Laj 40 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06482268

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • University of California San Diego, La Jolla
  • Keck School of Medicine of USC, Los Angeles
  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

  • San Francisco Research Institute, San Francisco
Ap rekriteVolontè an sante akeyi
Laj 40 a 80 · Tout sèks · Mizajou Jan 28, 2026 · NCT07220694

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

  • Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2022 · NCT04684602

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.